IL17A and rheumatoid arthritis: IL-1β, IL-6 and IL-17 mRNA was significantly increased in PBS- and HDF-applied RA mice, but the expression was significantly suppressed in cdMSC- and ATMSC-treated RA mice (Fig. 4F).